Acute secondary stroke prevention trials in minor stroke/TIA: Prime time for magnetic resonance imaging

International Journal of Stroke

Volumn 1, Issue 2, 2006, Pages 91-93

  Demchuk, Andrew M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; NEUROPROTECTIVE AGENT; TROPONIN;

ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE COURSE; EARLY DIAGNOSIS; EMERGENCY CARE; HIGH RISK PATIENT; HUMAN; NEUROIMAGING; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REVASCULARIZATION; RISK ASSESSMENT; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; TRANSIENT ISCHEMIC ATTACK;

HUMANS; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; RECURRENCE; STROKE;

EID: 33646152347     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2006.00022.x     Document Type: Article

References (31)

1. Rothwell PM, Coull AJ, Giles MF et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363: 1925-33.
2. Barber PA, Zhang J, Demchuk AM et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56: 1015-20.
3. Johnston SC, Gress DR, Browner WS et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 2901-6.
4. Chen ZM, Sandercock P, Pan HC et al. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 2000; 31: 1240-9.
5. Rothwell PM, Eliasziw M, Gutnikov SA et al. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855-61.
6. Kennedy J, Eliasziw M, Hill M et al. The fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER) trial. Sem Cerebrovasc Dis Stroke 2003; 3: 1-6.
7. Rothwell PM, Giles MF, Flossmann E et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005; 366: 29-36.
8. Eliasziw M, Kennedy J, Hill MD et al. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 2004; 170: 1105-9.
9. Valton L, Larrue V, le Traon AP et al. Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke 1998; 29: 2125-8.
10. Markus HS, MacKinnon A: Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke 2005; 36: 971-5.
11. Levi CR, Roberts AK, Fell G et al. Transcranial Doppler microembolus detection in the identification of patients at high risk of perioperative stroke. Eur J Vasc Endovasc Surg 1997; 14: 170-6.
12. Douglas VC, Johnston CM, Elkins J et al. Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke 2003; 34: 2894-8.
13. van Everdingen KJ, van der Grond J, Kappelle LJ et al. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998; 29: 1783-90.
14. Kidwell CS, Alger JR, Di Salle F et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 1999; 30: 1174-80.
15. Takayama H, Mihara B, Kobayashi M et al. Usefulness of diffusion-weighted MRI in the diagnosis of transient ischemic attacks. No To Shinkei 2000; 52: 919-23.
16. Purroy F, Montaner J, Rovira A et al. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004; 35: 2313-9.
17. Crisostomo RA, Garcia MM, Tong DC: Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: Correlation with clinical characteristics. Stroke 2003; 34: 932-7.
18. Ay H, Oliveira-Filho J, Buonanno FS et al. 'Footprints' of transient ischemic attacks: A diffusion-weighted MRI study. Cerebrovasc Dis 2002; 14: 177-86.
19. Rovira A, Rovira-Gols A, Pedraza S et al. Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks. Am J Neuroradiol 2002; 23: 77-83.
20. Inatomi Y, Kimura K, Yonehara T et al. DWI abnormalities and clinical characteristics in TIA patients. Neurology 2004; 62: 376-80.
21. Coutts SB, Simon JE, Eliasziw M et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005; 57: 848-54.
22. Coutts SB, Hill MD, Simon JE et al. Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology 2005; 65: 513-7.
23. Hand PJ, Wardlaw JM, Rowat AM et al. Magnetic resonance brain imaging in patients with acute stroke: Feasibility and patient related difficulties. J Neurol Neurosurg Psychiatr 2005; 76: 1525-7.
24. Barber PA, Hill MD, Eliasziw M et al. Imaging of the brain in acute ischaemic stroke: Comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005; 76: 1528-33.
25. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331-7.
26. Topol EJ, Easton D, Harrington RA et al. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation 2003; 108: 399-406.
27. Rothwell PM: Lessons from MATCH for future randomised trials in secondary prevention of stroke. Lancet 2004; 364: 305-7.
28. Imaizumi T, Horita Y et al. Dotlike hemosiderin spots on T2 * -weighted magnetic resonance imaging as a predictor of stroke recurrence: A prospective study. J Neurosurg 2004; 101: 915-20.
29. Greenberg SM, Eng JA, Ning M et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004; 35: 1415-20.
30. Forder JP, Munzenmaier DH, Greene AS: Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat. Am J Physiol Heart Circ Physiol 2005; 288: H1989-96.
31. Bristow MS, Simon JE, Brown RA et al. MR perfusion and diffusion in acute ischemic stroke: Human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab 2005; 25: 1280-7.